• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[晚期乳腺癌的抗雌激素与孕激素序贯疗法]

[Sequential therapy with antiestrogens and progestational drugs in carcinoma of the breast in an advanced stage].

作者信息

Palmeri R, Papalia E, Lazzara S, Belnome N A, Gorgone S, Calbo E, Melita P

机构信息

Università degli Studi di Messina, Istituto di Chirurgia Generale.

出版信息

Chir Ital. 1987 Apr;39(2):185-92.

PMID:2958166
Abstract

After discussing the mechanism of action of antioestrogens and medroxy-progesterone-acetate, the authors report on their experience with the sequential use of these two hormones in a group of patients with advanced cancer of the breast. After illustrating the results of their study, the authors conclude by stressing that the sequential use of these drugs appears to improve the quality of life of the patients with a significant increase in rates of complete or partial remission of the neoplastic disease.

摘要

在讨论了抗雌激素药物和醋酸甲羟孕酮的作用机制后,作者报告了他们在一组晚期乳腺癌患者中序贯使用这两种激素的经验。在阐述了研究结果后,作者强调,序贯使用这些药物似乎能提高患者的生活质量,肿瘤疾病的完全或部分缓解率显著提高。

相似文献

1
[Sequential therapy with antiestrogens and progestational drugs in carcinoma of the breast in an advanced stage].[晚期乳腺癌的抗雌激素与孕激素序贯疗法]
Chir Ital. 1987 Apr;39(2):185-92.
2
[Results of tamoxifen-medroxyprogesterone acetate sequential therapy in 22 patients with recurrent breast cancer].
Gan To Kagaku Ryoho. 1989 Nov;16(11):3555-8.
3
[Metastatic breast cancer: a comparative study of the efficacy of tamoxifen and the sequential administration of tamoxifen and medroxyprogesterone acetate].[转移性乳腺癌:他莫昔芬与他莫昔芬和醋酸甲羟孕酮序贯给药疗效的比较研究]
Bull Cancer. 1984;71(1):22-9.
4
Clinical trial of combined hormone therapy (MAP + TAM) for metastatic breast cancer.转移性乳腺癌联合激素治疗(MAP + TAM)的临床试验。
Chemioterapia. 1984 Aug;3(4):211-5.
5
[Phase II study of medroxyprogesterone acetate in advanced breast cancer].醋酸甲羟孕酮治疗晚期乳腺癌的II期研究
Gan To Kagaku Ryoho. 1986 Oct;13(11):3198-202.
6
[Mammary gland carcinoma treated by large-dose medroxyprogesterone acetate of which pulmonary metastases disappeared and a selection of hormone, chemoimmunological treatment].
Gan To Kagaku Ryoho. 1989 Jul;16(7):2457-9.
7
[Effects of neoadjuvant intra-arterial infusion chemotherapy in patients with stage III breast carcinoma].[新辅助动脉内灌注化疗对III期乳腺癌患者的影响]
Gan To Kagaku Ryoho. 1997 Sep;24(12):1799-802.
8
[Metastatic breast carcinoma: sequential hormonotherapy with tamoxifen and medroxy-progesterone acetate. preliminary results].[转移性乳腺癌:他莫昔芬与醋酸甲羟孕酮序贯激素治疗。初步结果]
Bull Cancer. 1982;69(2):170-1.
9
[Adjuvant hormone therapy in endometrial carcinoma: medroxyprogesterone acetate versus tamoxifen-medroxyprogesterone acetate sequential therapy].
Gynakol Rundsch. 1990;30(3):133-43.
10
[Chemo-endocrine therapy of advanced breast cancer].
Gan To Kagaku Ryoho. 1988 Dec;15(12):3214-20.